- 全部删除
您的购物车当前为空
T863 (DGAT-3) 是口服有效的二酰基甘油酰基转移酶1 选择性抑制剂。T863结合DGAT1的酰基辅酶A 结合位点,抑制三酰甘油在细胞内的合成。


为众多的药物研发团队赋能,
让新药发现更简单!
T863 (DGAT-3) 是口服有效的二酰基甘油酰基转移酶1 选择性抑制剂。T863结合DGAT1的酰基辅酶A 结合位点,抑制三酰甘油在细胞内的合成。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 322 | In stock | |
| 2 mg | ¥ 449 | In stock | |
| 5 mg | ¥ 712 | In stock | |
| 10 mg | ¥ 1,230 | In stock | |
| 25 mg | ¥ 2,430 | In stock | |
| 50 mg | ¥ 3,590 | In stock | |
| 100 mg | ¥ 5,120 | In stock | |
| 200 mg | ¥ 7,250 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 617 | In stock |
T863 相关产品
| 产品描述 | T-863(DGAT-1 inhibitor) is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells. IC50 value: Target: DGAT1 T863 (DGAT-3) causes weight loss, reduction in serum and liver triglycerides, and improved insulin sensitivity in obese mice. |
| 别名 | DGAT-3, DGAT-1 inhibitor |
| 分子量 | 394.47 |
| 分子式 | C22H26N4O3 |
| CAS No. | 701232-20-4 |
| Smiles | CC1(C)Oc2ncnc(N)c2N=C1c1ccc(cc1)[C@H]1CC[C@H](CC(O)=O)CC1 |
| 密度 | 1.36 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45 mg/mL (114.08 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容